2022 年脂肪纳米粒 LNP 研究报告 - 过去出现在与未来机遇英文版 7 页

Lipid Nanoparticles (LNPs) have been a key player in drug delivery systems for decades, with a recent focus on their role in COVID-mRNA vaccines. They are versatile carriers for hydrophobic and hydrophilic molecules and have been approved for various treatments, including antitumor agents and protein antigens. The development of LNP technology has progressed significantly over the years, with advancements in liposome formation and targeting. The CAS Content Collection™ provides a unique landscape of LNP-related research, including emerging trends and opportunities. Overall, LNP technology continues to be an important area of research with potential applications in medical imaging, nutrients, cosmetics, agriculture, and more.

各类投资研究报告查询就上发现报告平台（www.fxbaogao.com），平台数据库庞大，研报分类完整细致，全量覆盖宏观走势、产业行业、上市企业、季度年报等板块。平台用户体量稳居行业前列，结合前沿信息技术与极简浏览布局，大幅降低信息获取门槛，辅助用户深度研判市场行情。